A selective peptide discussed in relation to growth-hormone-pulse signaling.
Ipamorelin is a selective peptide studied for how it may prompt a growth-hormone pulse through the ghrelin-receptor pathway — a different route than GHRH analogs.
It is often discussed as comparatively selective, with less reported effect on other hormones. “Selective” is a useful description, not a promise of safety or benefit.
It is described as mimicking ghrelin at its receptor and dampening somatostatin (a signal that slows GH release), which is why it is frequently paired with GHRH analogs in discussion.
It appears in GH-axis conversations, usually as a complement to CJC-1295 or Sermorelin.
Discussed as an injectable in research settings. Context and oversight determine appropriateness.
Science. Precision. Potential.
The content on this site is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before making decisions about your health.
We believe in evidence-informed education, transparency, and personal responsibility. Our goal is to provide accurate information so you can make informed choices aligned with your values and health goals.